Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Observational Study to Evaluate Clinical Practice and Satisfaction With Metvix® Daylight Photodynamic Therapy (PDT) in the Treatment of Mild and/or Moderate Actinic Keratosis of the Face and/or the Scalp

NCT02674048 is registered in ClinicalTrials.gov with Galderma R&D as lead sponsor.

NCT NCT02674048
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02674048 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Observational Study to Evaluate Clinical Practice and Satisfaction With Metvix® Daylight Photodynamic Therapy (PDT) in the Treatment of Mild and/or Moderate Actinic Keratosis of the Face and/or the Scalp
Lead sponsor
Galderma R&D
Phase
Observational
Overall status
Completed
Start date
September 30, 2015
Completion date
November 30, 2016
Enrollment
406 (actual)
Sites
7

Conditions

As the registry lists them; a condition with its own page is linked.

actinic keratosis